Premium
Q32 Bio Inc (QTTB)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Atlas Venture Advisors, Inc. | Institution | 2 717 106 | 16,02% | US$ 38,04M | 2026-05-28 |
| OrbiMed Advisors LLC | Institution | 2 252 987 | 13,29% | US$ 31,54M | 2026-05-05 |
| Orbimed Private Investments VII, LP | Institution | 2 252 987 | 13,29% | US$ 31,54M | 2026-05-05 |
| Opaleye Management Inc. | Institution | 1 256 228 | 7,41% | US$ 17,59M | 2026-03-31 |
| Opaleye L.P | Institution | 1 256 228 | 7,41% | US$ 17,59M | 2026-03-31 |
| Abingworth LLP | Institution | 1 102 741 | 6,50% | US$ 15,44M | 2026-03-31 |
| Sirenia Capital Management LP | Institution | 1 031 654 | 6,08% | US$ 14,44M | 2026-03-31 |
| Point72 Associates, LLC | Institution | 1 031 654 | 6,08% | US$ 14,44M | 2026-02-18 |
| Atlas Venture Fund X, L.P. | Institution | 864 261 | 5,10% | US$ 12,10M | 2026-05-28 |
| Atlas Venture Opportunity Fund II, L.P. | Institution | 724 549 | 4,27% | US$ 10,14M | 2026-05-28 |
| Atlas Venture Opportunity Fund Ill, L.P. | Institution | 625 000 | 3,69% | US$ 8,75M | 2026-05-28 |
| Atlas Venture Opportunity Fund I | Institution | 503 296 | 2,97% | US$ 7,05M | 2026-05-28 |
| Arch Venture Partners, L.P. | Institution | 320 482 | 1,89% | US$ 4,49M | 2026-03-31 |
| Acorn Bioventures | Institution | 315 052 | 1,86% | US$ 4,41M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 306 401 | 1,81% | US$ 4,29M | 2026-03-31 |
| Mackenzie Financial Corporation | Institution | 246 304 | 1,45% | US$ 3,45M | 2026-03-31 |
| Sanofi | Institution | 244 083 | 1,44% | US$ 3,42M | 2026-03-31 |
| Renaissance Technologies LLC | Institution | 206 915 | 1,22% | US$ 2,90M | 2026-03-31 |
| Bristol-Myers Squibb Company | Institution | 200 244 | 1,18% | US$ 2,80M | 2024-12-31 |
| Acadian Asset Management LLC | Institution | 172 586 | 1,02% | US$ 2,42M | 2026-03-31 |
| Monimus Capital Management, LP | Institution | 134 310 | 0,79% | US$ 1,88M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 118 152 | 0,70% | US$ 1,65M | 2026-03-31 |
| Pfizer Venture Investments LLC | Institution | 101 618 | 0,60% | US$ 1,42M | 2026-03-31 |
| BlackRock, Inc. | Institution | 86 147 | 0,51% | US$ 1,21M | 2026-03-31 |
| Dr. Shelia Violette | Initiés | 73 096 | 0,43% | US$ 1,02M | 2026-02-25 |
| Jane Street Group, LLC | Institution | 65 599 | 0,39% | US$ 918,39k | 2026-03-31 |
| Marshall Wace LLP | Institution | 52 440 | 0,31% | US$ 734,16k | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 49 995 | 0,29% | US$ 699,93k | 2026-03-31 |
| Two Sigma Investments, LP | Institution | 42 346 | 0,25% | US$ 592,84k | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 41 514 | 0,24% | US$ 581,20k | 2026-03-31 |
| Cambridge Investment Research Advisors, Inc. | Institution | 35 025 | 0,21% | US$ 490,35k | 2026-03-31 |
| ADAR1 Capital Management, LLC | Institution | 35 000 | 0,21% | US$ 490,00k | 2026-03-31 |
| Affinity Asset Advisors, LLC | Institution | 27 777 | 0,16% | US$ 388,88k | 2026-03-31 |
| Northern Trust Global Investments | Institution | 25 033 | 0,15% | US$ 350,46k | 2026-03-31 |
| Ms. Jodie Morrison | Initiés | 23 104 | 0,14% | US$ 323,46k | 2026-02-25 |
| Dimensional Fund Advisors LP | Institution | 20 808 | 0,12% | US$ 291,31k | 2026-04-30 |
| Cetera Investment Advisers LLC | Institution | 20 695 | 0,12% | US$ 289,73k | 2026-03-31 |
| American Century Investment Management Inc | Institution | 18 770 | 0,11% | US$ 262,78k | 2026-03-31 |
| Citadel Advisors LLC | Institution | 15 481 | 0,09% | US$ 216,73k | 2026-03-31 |
| Bridgeway Capital Management, LLC | Institution | 12 613 | 0,07% | US$ 176,58k | 2026-03-31 |
| Mr. Lee Kalowski | Initiés | 9 318 | 0,05% | US$ 130,45k | 2026-02-24 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
